Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Camlin Fine SciencesNSE:CAMLINFINE -0.98%62 Equity-to-Asset is 0.45 as of Mar. 2026, which is 10% above its 10-year median of 0.41. GuruFocus rates NSE:CAMLINFINE with a GF Score™ of 62/100 and a GF Value™ of ₹144.35 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,614 Chemicals companies, Camlin Fine Sciences ranks worse than 71.19% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Camlin Fine Sciences's Total Stockholders Equity for the quarter that ended in Mar. 2026 was ₹10,409 Mil. Camlin Fine Sciences's Total Assets for the quarter that ended in Mar. 2026 was ₹23,239 Mil.
Therefore, Camlin Fine Sciences's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.45.
The historical rank and industry rank for Camlin Fine Sciences's Equity-to-Asset or its related term are showing as below:
NSE:CAMLINFINE'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.32 Med: 0.41 Max: 0.45
Current: 0.45
During the past 13 years, the highest Equity to Asset Ratio of Camlin Fine Sciences was 0.45. The lowest was 0.32. And the median was 0.41.
NSE:CAMLINFINE's Equity-to-Asset is ranked worse than 71.19% of 1614
companies
in the Chemicals industry
Industry Median: 0.6
vs NSE:CAMLINFINE: 0.45
Camlin Fine Sciences (NSE:CAMLINFINE) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Camlin Fine Sciences Equity-to-Asset Related Terms
Camlin Fine Sciences Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Camlin Fine Sciences's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CAMLINFINE vs LIN, SHW, ECL: Equity-to-Asset Comparison
For the Specialty Chemicals subindustry, Camlin Fine Sciences's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Camlin Fine Sciences Equity-to-Asset vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Camlin Fine Sciences's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Camlin Fine Sciences's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Camlin Fine Sciences's Equity to Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Camlin Fine Sciences (NSE:CAMLINFINE) has a Equity-to-Asset of 0.45 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Camlin Fine Sciences and its competitors. This is 10% above median its historical median of 0.41. Over the past decade, Camlin Fine Sciences' Equity-to-Asset has ranged from 0.32 to 0.45. According to the industry distribution chart, Camlin Fine Sciences ranks #1149 out of 1614 companies in the Chemicals industry, placing it in the top 71.2%.
Is Camlin Fine Sciences' Equity-to-Asset too high?
Camlin Fine Sciences' current Equity-to-Asset of 0.45 is 10% above median its 10-year median of 0.41. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 0.45. The Chemicals industry median Equity-to-Asset is 0.60. Camlin Fine Sciences' value of 0.45 is 25% below this industry median. Based on the distribution chart, Camlin Fine Sciences ranks #1149 out of 1614 companies in the Chemicals industry, which is below the industry midpoint. Overall, Camlin Fine Sciences has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Camlin Fine Sciences' Equity-to-Asset compare to LIN and SHW?
According to the Chemicals industry distribution chart, Camlin Fine Sciences ranks #1149 out of 1614 companies for Equity-to-Asset. This places Camlin Fine Sciences in the lower half of its industry. The industry median Equity-to-Asset is 0.60. Camlin Fine Sciences' value of 0.45 is 25% below this benchmark. Historically, Camlin Fine Sciences' own Equity-to-Asset has ranged from 0.32 to 0.45 over the past decade. While the company's 10-year median is 0.41 vs. the industry median of 0.60, Camlin Fine Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Chemicals company?
The median Equity-to-Asset among Chemicals companies is 0.60, based on 1,614 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Camlin Fine Sciences's current Equity-to-Asset of 0.45 is 25% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Camlin Fine Sciences and its competitors. For the Chemicals industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Camlin Fine Sciences's current Equity-to-Asset is 0.45, which is 10% above median its own 10-year median of 0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Camlin Fine Sciences stock overvalued right now?
Based on GuruFocus' analysis, Camlin Fine Sciences (NSE:CAMLINFINE) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹144.35, compared to a current price of ₹126.58 — trading 12.3% below its estimated fair value. The current Equity-to-Asset is 0.45, which is 10% above median its 10-year median of 0.41 and 25% below the Chemicals industry median of 0.60. Camlin Fine Sciences' overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Camlin Fine Sciences (NSE:CAMLINFINE), the current Equity-to-Asset is 0.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Camlin Fine Sciences (NSE:CAMLINFINE) Overvalued in 2026?
Based on GuruFocus' analysis, Camlin Fine Sciences stock appears to be undervalued.
The current stock price of ₹126.58 is trading 12.3% below its estimated GF Value™ of ₹144.35.
GuruFocus considers Camlin Fine Sciences to be Modestly Undervalued.
Key valuation signals for NSE:CAMLINFINE:
Equity-to-Asset: 0.45 (10% above median its 10-year median of 0.41)
GF Value™: ₹144.35 vs. price of ₹126.58 (12.3% below fair value)
Industry Position: 25% below the Chemicals median (#1149 of 1614)
No single metric tells the full story. See the NSE:CAMLINFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Camlin Fine Sciences Ltd is engaged in research, development, manufacturing, commercializing, and marketing of specialty chemicals and blends. These chemicals are used in food, feed, animal and pet nutrition and industrial products. The Company has only one reportable segment, namely, Speciality Chemicals. The company's product portfolio consists of Shelf life solutions, Aroma ingredients, Performance chemicals and Health & Wellness. Shelf life extension solutions include antioxidant solutions which are used to increase the shelf life of oils and. Aroma vertical includes a production of Vanillin and Ethyl Vanillin. Performance Chemicals consist of Guaiacol, Veratrole, TBC, and MEHQ and are used in sectors such as food flavoring, pharmaceuticals intermediate fragrance industry.
62GF Score
Get the complete analysis for NSE:CAMLINFINE
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CAMLINFINE has been successfully added to your 
